The NUS High School of Mathematics and Science , NUSH, 20 Clementi Ave 1, Singapore, Singapore.
Programme in Cardiovascular and Metabolic Disorders (CVMD) and Centre for Computational Biology (CCB), Duke-NUS Medical School, 8 College Road, Singapore, Singapore.
BMC Nephrol. 2024 Oct 18;25(1):364. doi: 10.1186/s12882-024-03798-2.
Chronic Kidney Disease (CKD) impacts over 10% of the global population, and recent advancements in high-throughput analytical technologies are uncovering the complex physiology underlying this condition. By integrating Genome-Wide Association Studies (GWAS), RNA sequencing (RNA-seq/RNA array), and single-cell RNA sequencing (scRNA-seq) data, our study aimed to explore the genes and cell types relevant to CKD traits.
GWAS summary data for end-stage renal failure (ESRD) and decreased eGFR (CKD) with or without diabetes and (micro)proteinuria were obtained from the GWAS Catalog and the UK Biobank (UKB) database. Two gene Expression Omnibus (GEO) transcriptome datasets were used to establish glomerular and tubular gene expression differences between CKD patients and healthy individuals. Two scRNA-seq datasets were utilized to obtain the expression of key genes at the single-cell level. The expression profile, differentially expressed genes (DEGs), gene-gene interaction, and pathway enrichment were analysed for these CKD risk genes.
A total of 779 distinct SNPs were identified from GWAS across different CKD traits, involving 681 genes. While many of these risk genes are specific to the CKD traits of renal failure, decreased eGFR, and (micro)proteinuria, they share common pathways, including extracellular matrix (ECM). ECM modeling was enriched in upregulated glomerular and tubular DEGs from CKD kidneys compared to healthy controls, with the expression of relevant collagen genes, such as COL1A2, prevalent in fibroblasts/myofibroblasts. Additionally, immune responses, including T cell differentiation, were dysregulated in CKD kidneys. The late podocyte signature gene THSD7A was enriched in podocytes but downregulated in CKD. We also highlighted that the regulated risk genes of CKD are mainly expressed in tubular cells and immune cells in the kidney.
Our integrated analysis highlight the genes, pathways, and relevant cell types associational with the pathogenesis of kidney traits, as a basis for further mechanistic studies to understand the pathogenesis of CKD.
慢性肾脏病(CKD)影响着全球超过 10%的人口,高通量分析技术的最新进展揭示了这种疾病的复杂生理机制。通过整合全基因组关联研究(GWAS)、RNA 测序(RNA-seq/RNA 芯片)和单细胞 RNA 测序(scRNA-seq)数据,我们的研究旨在探索与 CKD 特征相关的基因和细胞类型。
从 GWAS 目录和英国生物库(UKB)数据库中获得终末期肾衰竭(ESRD)和 eGFR 降低(CKD)伴有或不伴有糖尿病和(微量)蛋白尿的 GWAS 汇总数据。使用两个基因表达综合资源(GEO)转录组数据集来建立 CKD 患者与健康个体之间肾小球和肾小管基因表达差异。利用两个 scRNA-seq 数据集获得关键基因在单细胞水平的表达。对这些 CKD 风险基因进行表达谱、差异表达基因(DEGs)、基因-基因相互作用和通路富集分析。
从不同的 CKD 特征的 GWAS 中总共鉴定出 779 个独特的 SNP,涉及 681 个基因。虽然这些风险基因中的许多是肾衰竭、eGFR 降低和(微量)蛋白尿等 CKD 特征所特有的,但它们共享共同的途径,包括细胞外基质(ECM)。与健康对照组相比,CKD 肾脏中上调的肾小球和肾小管 DEGs 中富集了 ECM 建模,相关胶原基因如 COL1A2 在成纤维细胞/肌成纤维细胞中表达。此外,CKD 肾脏中的免疫反应,包括 T 细胞分化,也失调了。晚期足细胞标志基因 THSD7A 在足细胞中富集,但在 CKD 中下调。我们还强调,CKD 的调控风险基因主要在肾脏中的肾小管细胞和免疫细胞中表达。
我们的综合分析强调了与肾脏特征发病机制相关的基因、途径和相关细胞类型,为进一步的机制研究提供了基础,以了解 CKD 的发病机制。